Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Accenture
US Department of Justice
Julphar
Teva
Covington
Harvard Business School
Baxter
Merck

Generated: December 12, 2018

DrugPatentWatch Database Preview

Claims for Patent: 4,254,129

« Back to Dashboard

Summary for Patent: 4,254,129
Title: Piperidine derivatives
Abstract:Novel compounds of the following formula: ##STR1## wherein R.sub.1 is hydrogen or hydroxy; R.sub.2 is hydrogen; or R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2 ; n is an integer of from 1 to 5; R.sub.3 is --CH.sub.3, --CH.sub.2 OH, --COOH or --COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched; and each of A and B is hydrogen or hydroxy; with the provisos that at least one of A or B is hydrogen and one of A or B is other than hydrogen when R.sub.3 is --CH.sub.3 ; and pharmaceutically acceptable salts thereof.
Inventor(s): Carr; Albert A. (Cincinnati, OH), Dolfini; Joseph E. (Cincinnati, OH), Wright; George J. (Richmond, VA)
Assignee: Richardson-Merrell Inc. (Wilton, CT)
Application Number:06/028,813
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,254,129
Patent Claims: 1. A compound of the formula ##STR13## wherein R.sub.1 represents hydrogen or hydroxy; R.sub.2 represents hydrogen; or R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2 ; n is an integer of from 1 to 5; R.sub.3 is --COOH or --COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched; each of A and B is hydrogen or hydroxy; with the proviso that at least one of A or B is hydrogen; and pharmaceutically acceptable salts and individual optical isomers thereof.

2. A compound of claim 1 wherein R.sub.1 is hydrogen or R.sub.1 and R.sub.2 taken together form a second bond between the carbon atoms bearing R.sub.1 and R.sub.2.

3. A compound of claim 2 wherein n is 3 or 4.

4. A compound of claim 2 wherein R.sub.3 is --COOalkyl.

5. A compound of claim 2 wherein R.sub.3 is --COOH.

6. A compound of claim 1 of the formula ##STR14## wherein R.sub.4 is hydroxy and R.sub.5 is hydrogen, or R.sub.4 and R.sub.5 taken together form a second bond between the carbon atoms beraing R.sub.4 and R.sub.5 ; n is the integer 3; and R.sub.3 is --COOH or a pharmaceuticaly acceptable salt thereof.

7. A compound of claim 1 which is ethyl 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-.alpha.,.al pha.-dimethylbenzene acetate or a pharmaceutically acceptable salt thereof.

8. A compound of claim 1 which is 4-[4-[-4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-.alpha.,.a lpha.-dimethylbenzeneacetic acid or a pharmaceutically acceptable salt thereof.

9. A compound of claim 1 which is 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-.alpha.,.al pha.-dimethyl-(3-hydroxybenzene)acetic acid or a pharmaceutically acceptable salt thereof.

10. A pharmaceutical composition in unit dosage form comprising an effective antiallergic amount of a compound of claim 1 and a significant amount of a pharmaceutically acceptable carrier.

11. A method of treating allergic reactions in a patient in need thereof which comprises administering to said patient an effective amount of a compound of claim 1.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Cipla
Chubb
Express Scripts
Chinese Patent Office
Deloitte
Queensland Health
Colorcon
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.